Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
2.700
-0.160 (-5.59%)
Dec 20, 2024, 4:00 PM EST - Market closed
Skye Bioscience Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Skye Bioscience stock have an average target of 18.67, with a low estimate of 14 and a high estimate of 25. The average target predicts an increase of 591.48% from the current stock price of 2.70.
Analyst Consensus: Buy
* Price targets were last updated on Sep 30, 2024.
Analyst Ratings
The average analyst rating for SKYE stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Initiates $20 | Buy | Initiates | $20 | +640.74% | Sep 30, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $20 | Buy | Reiterates | $20 | +640.74% | Sep 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +418.52% | Sep 20, 2024 |
| JMP Securities | JMP Securities | Buy Initiates $15 | Buy | Initiates | $15 | +455.56% | Sep 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +418.52% | Sep 9, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.90
from -5.37
EPS Next Year
-1.17
from -0.90
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.79 | -1.04 | -1.17 | |||
| Avg | -0.90 | -1.17 | -1.50 | |||
| Low | -1.23 | -1.30 | -1.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.